These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 36174640)
1. Faecal microbiota transplantation in patients with haematological malignancies undergoing cellular therapies: from translational research to routine clinical practice. Malard F; Gaugler B; Mohty M Lancet Haematol; 2022 Oct; 9(10):e776-e785. PubMed ID: 36174640 [TBL] [Abstract][Full Text] [Related]
2. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning. Petersen SL Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527 [TBL] [Abstract][Full Text] [Related]
3. Fecal microbiota transplantation before or after allogeneic hematopoietic transplantation in patients with hematologic malignancies carrying multidrug-resistance bacteria. Battipaglia G; Malard F; Rubio MT; Ruggeri A; Mamez AC; Brissot E; Giannotti F; Dulery R; Joly AC; Baylatry MT; Kossmann MJ; Tankovic J; Beaugerie L; Sokol H; Mohty M Haematologica; 2019 Aug; 104(8):1682-1688. PubMed ID: 30733264 [TBL] [Abstract][Full Text] [Related]
4. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers. Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412 [TBL] [Abstract][Full Text] [Related]
5. Gut microbiota and acute graft-versus-host disease. Yoshioka K; Kakihana K; Doki N; Ohashi K Pharmacol Res; 2017 Aug; 122():90-95. PubMed ID: 28576475 [TBL] [Abstract][Full Text] [Related]
6. The impact of intestinal microbiota in antithymocyte globulin-based myeloablative allogeneic hematopoietic cell transplantation. Gu Z; Xiong Q; Wang L; Wang L; Li F; Hou C; Dou L; Zhu B; Liu D Cancer; 2022 Apr; 128(7):1402-1410. PubMed ID: 35077579 [TBL] [Abstract][Full Text] [Related]
7. Graft-versus-host disease risk after chimeric antigen receptor T-cell therapy: the diametric opposition of T cells. Sanber K; Savani B; Jain T Br J Haematol; 2021 Dec; 195(5):660-668. PubMed ID: 34036558 [TBL] [Abstract][Full Text] [Related]
8. Gut microbiota, microbiota-derived metabolites, and graft-versus-host disease. Yue X; Zhou H; Wang S; Chen X; Xiao H Cancer Med; 2024 Feb; 13(3):e6799. PubMed ID: 38239049 [TBL] [Abstract][Full Text] [Related]
9. The role of the intestinal microbiota in allogeneic HCT: clinical associations and preclinical mechanisms. Nguyen CL; Docampo MD; van den Brink MR; Markey KA Curr Opin Genet Dev; 2021 Feb; 66():25-35. PubMed ID: 33388483 [TBL] [Abstract][Full Text] [Related]
10. Advances in understanding the pathogenesis of graft-versus-host disease. Magenau J; Runaas L; Reddy P Br J Haematol; 2016 Apr; 173(2):190-205. PubMed ID: 27019012 [TBL] [Abstract][Full Text] [Related]
11. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut]. Kakihana K Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766 [TBL] [Abstract][Full Text] [Related]
12. Crosstalk Between Intestinal Microbiota Derived Metabolites and Tissues in Allogeneic Hematopoietic Cell Transplantation. Fujiwara H Front Immunol; 2021; 12():703298. PubMed ID: 34512627 [TBL] [Abstract][Full Text] [Related]
13. Targeting the gut microbiome: An emerging trend in hematopoietic stem cell transplantation. Ciernikova S; Kasperova B; Drgona L; Smolkova B; Stevurkova V; Mego M Blood Rev; 2021 Jul; 48():100790. PubMed ID: 33573867 [TBL] [Abstract][Full Text] [Related]
14. Faecal microbiota transplantation in the treatment of recurrent intestinal Clostridioides difficile infection - a ten-year single-center experience. Pipek B; Valentová H; Fojtík P; Urban O Cas Lek Cesk; 2022; 161(3-4):126-130. PubMed ID: 36100450 [TBL] [Abstract][Full Text] [Related]